New hope for stubborn high cholesterol: pemafibrate trial launches
Disease control
Recruiting now
This study tests a drug called pemafibrate in 120 adults with high cholesterol that remains high even after taking statins. Participants will take either a low or higher dose of pemafibrate or a placebo pill daily for 12 weeks. The goal is to see if pemafibrate can safely lower c…
Phase: PHASE4 • Sponsor: Kowa Company, Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC